ArticleCellular and molecular life sciences : CMLS2026
Host E3 ligase RNF2 restricts African swine fever virus replication through targeting viral pA104R for its K5 site ubiquitination degradation.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The African swine fever virus (ASFV) -encoded late structural protein pA104R is a putative histone-like protein, which is also a DNA-binding related protein required for ASFV DNA replication, transcription, and genome packaging. However, the molecular mechanism underlying pA104R-host protein interactions remain unknown. To identify proteins potentially interacting with ASFV-pA104R, a primary porcine alveolar macrophage (PAM) cDNA yeast two-hybrid library was constructed, and the pig E3 ubiquitin ligase RING-finger protein 2 (RNF2) was identified, which specifically negatively regulates the proliferation of ASFV. Mechanistically, RNF2 inhibits ASFV replication by promoting the proteasomal degradation of ASFV-pA104R through K48-linked ubiquitination at pA104R lysine 5 (K5). Further studies showed that the K5R mutation impairs the interaction between pA104R and RNF2 and antagonizes for pA104R degradation by RNF2. An ASFV mutant carrying a pA104R point mutation (ASFV CN/SC/2019 pA104R-K5R) was generated based on the ASFV CN/SC/2019 (wild-type) strain. Furthermore, our findings indicate that ASFV CN/SC/2019 pA104R-K5R enhances viral replication and virulence, potentially by increasing viral transcription and/or modulating the host immune response. Accordingly, compared with the parental strain, ASFV CN/SC/2019 pA104R-K5R was more pathogenic and severe lesions in swine. Collectively, our study identifies an intrinsic antiviral protein RNF2 that mediates ASFV CN/SC/2019 pA104R-K5 site ubiquitination emerges as a potential determinant of viral replication and pathogenicity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.